ID   H3922
AC   CVCL_0283
DR   MCCL; MCC:0000174
DR   Wikidata; Q54872124
RX   PubMed=9186000;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
RX   PubMed=9186000;
RA   Liu, Jing-Wen
RA   Spence, Michael J.
RA   Wallace, Philip M.
RA   Forcier, Kristin
RA   Hellstrom, Ingegerd
RA   Vestal, Robert E.
RT   "Oncostatin M-specific receptor mediates inhibition of breast cancer
RT   cell growth and down-regulation of the c-myc proto-oncogene.";
RL   Cell Growth Differ. 8:667-676(1997).
//
RX   PubMed=11839257; DOI=10.1089/15368590152740798;
RA   Pancook, James David
RA   Beuerlein, Gregory
RA   Pecht, Gerlinde
RA   Tang, Ying
RA   Nie, Ying
RA   Wu, Herren
RA   Huse, William D.
RA   Watkins, Jeffry D.
RT   "In vitro affinity maturation of human IgM antibodies reactive with
RT   tumor-associated antigens.";
RL   Hybrid. Hybridomics 20:383-396(2001).
//